These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4254277)

  • 1. Electrophysiological mechanisms underlying pharmacological models of cardiac fibrillation.
    Antoni H
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):177-99. PubMed ID: 4254277
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 3. Arrhythmias and antiarrhythmic agents.
    Heddle WF; Tonkin AM
    Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of ventricular arrhythmias.
    Fogoros RN
    Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
    [No Abstract]   [Full Text] [Related]  

  • 7. New paradigm for drug therapies of cardiac fibrillation.
    Karma A
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5687-9. PubMed ID: 10823928
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M; Noll B; Krappe J
    Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy of patients with arrhythmias associated with bypass tracts.
    Wellens HJ; Brugada P; Abdollah H
    Ann N Y Acad Sci; 1984; 432():272-8. PubMed ID: 6395764
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods for the detection and assessment of antiarrhythmic activity.
    Winslow E
    Pharmacol Ther; 1984; 24(3):401-33. PubMed ID: 6379687
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiological basis for a rational approach to antidysrhythmic drug therapy.
    Williams EM
    Adv Drug Res; 1974; 9():69-101. PubMed ID: 4618979
    [No Abstract]   [Full Text] [Related]  

  • 12. New perspectives in the pharmacologic therapy of cardiac arrhythmias.
    Singh BN; Collett JT; Chew CY
    Prog Cardiovasc Dis; 1980; 22(4):243-301. PubMed ID: 6986060
    [No Abstract]   [Full Text] [Related]  

  • 13. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding role of SK channels in cardiac electrophysiology.
    Mahida S
    Heart Rhythm; 2014 Jul; 11(7):1233-8. PubMed ID: 24681007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cardiac arrhythmias.
    Robinson SJ
    Pediatr Clin North Am; 1964 May; 11(2):315-62. PubMed ID: 4174540
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent.
    Georges A; Hosslet A; Duvernay G
    Acta Cardiol; 1973; 28(2):166-91. PubMed ID: 4540792
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac vulnerability.
    Surawicz B; Steffens T
    Cardiovasc Clin; 1973; 5(3):159-81. PubMed ID: 4601967
    [No Abstract]   [Full Text] [Related]  

  • 20. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation.
    Dobrev D
    J Interv Card Electrophysiol; 2008 Aug; 22(2):107-10. PubMed ID: 18330686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.